GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atrys Health SA (XMAD:ATRY) » Definitions » FCF Margin %

Atrys Health (XMAD:ATRY) FCF Margin % : -2.00% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Atrys Health FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Atrys Health's Free Cash Flow for the six months ended in Dec. 2023 was €-1.7 Mil. Atrys Health's Revenue for the six months ended in Dec. 2023 was €83.3 Mil. Therefore, Atrys Health's FCF Margin % for the quarter that ended in Dec. 2023 was -2.00%.

As of today, Atrys Health's current FCF Yield % is -4.87%.

The historical rank and industry rank for Atrys Health's FCF Margin % or its related term are showing as below:

XMAD:ATRY' s FCF Margin % Range Over the Past 10 Years
Min: -52.18   Med: -20.31   Max: -3.2
Current: -7.07


During the past 8 years, the highest FCF Margin % of Atrys Health was -3.20%. The lowest was -52.18%. And the median was -20.31%.

XMAD:ATRY's FCF Margin % is ranked better than
74.52% of 1044 companies
in the Biotechnology industry
Industry Median: -139.2 vs XMAD:ATRY: -7.07


Atrys Health FCF Margin % Historical Data

The historical data trend for Atrys Health's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atrys Health FCF Margin % Chart

Atrys Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial -25.07 -21.29 -3.20 -19.32 -7.07

Atrys Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.14 -17.32 -21.88 -10.63 -2.00

Competitive Comparison of Atrys Health's FCF Margin %

For the Biotechnology subindustry, Atrys Health's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atrys Health's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atrys Health's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Atrys Health's FCF Margin % falls into.



Atrys Health FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Atrys Health's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-14.241/201.569
=-7.07 %

Atrys Health's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-1.668/83.333
=-2.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Atrys Health FCF Margin % Related Terms

Thank you for viewing the detailed overview of Atrys Health's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Atrys Health (XMAD:ATRY) Business Description

Traded in Other Exchanges
Address
c/ Provença, 392 planta baja, Barcelona, ESP, 08025
Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.

Atrys Health (XMAD:ATRY) Headlines

No Headlines